Novel strategies for medical management of obesity: mechanisms, clinical implications, and societal impactsa report from the 25th Annual Harvard Nutrition Obesity Symposium The American Journal of Clinical Nutrition Efficacy and safety of co administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, Quarterly Drug Pipeline: April 2026 Prime Therapeutics Portal Cagrilintide Dosage and Weight Loss Guide PEP DOSE Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination https: www.mdc berlin.de de veroeffentlichungstypen clinical journal club